Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Calhoun

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
Diabetes Technology & Therapeutics|June 9, 2023
The Type 1 Diabetes and EXercise Initiative: Predicting Hypoglycemia Risk During Exercise for Participants with Type 1 Diabetes Using Repeated Measures Random ForestSimon Bergford, Michael C Riddell, Peter G Jacobs, et al.
The New England Journal of Medicine|September 7, 2022
Closed-Loop Therapy and Preservation of C-Peptide Secretion in Type 1 DiabetesCharlotte K Boughton, Janet M Allen, Julia Ware, et al.
Diabetes Technology & Therapeutics|September 29, 2022
A Multicenter Randomized Trial Evaluating the Insulin-Only Configuration of the Bionic Pancreas in Adults with Type 1 DiabetesDavida Kruger, Alex Kass, Jacqueline Lonier, et al.
Diabetes Care|June 26, 2024
Effect of 48 Months of Closed-Loop Insulin Delivery on Residual C-Peptide Secretion and Glycemic Control in Newly Diagnosed Youth With Type 1 Diabetes: A Randomized TrialJulia Ware, Charlotte K Boughton, Janet M Allen, et al.
Diabetologia|March 19, 2024
Associations between daily step count classifications and continuous glucose monitoring metrics in adults with type 1 diabetes: analysis of the Type 1 Diabetes Exercise Initiative (T1DEXI) cohortLauren V Turner, Martin Chase Marak, Robin L Gal, et al.
Journal of the Endocrine Society|September 1, 2020
Diabetes Telehealth Solutions: Improving Self-Management Through Remote Initiation of Continuous Glucose MonitoringRobin L Gal, Nathan J Cohen, Davida Kruger, et al.
Diabetes Technology & Therapeutics|June 28, 2022
WITHDRAWN: Positive Impact of the Bionic Pancreas on Diabetes Control in Youth 6-17 Years Old with Type 1 Diabetes: A Multicenter Randomized TrialLaurel H Messer, Bruce A Buckingham, Fran Cogen, et al.
Lancet (London, England)|January 17, 2021
A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trialRichard M Bergenstal, Revital Nimri, Roy W Beck, et al.
Diabetes Technology & Therapeutics|September 29, 2022
Positive Impact of the Bionic Pancreas on Diabetes Control in Youth 6-17 Years Old with Type 1 Diabetes: A Multicenter Randomized TrialLaurel H Messer, Bruce A Buckingham, Fran Cogen, et al.
Diabetes Technology & Therapeutics|May 2, 2024
Multicenter Evaluation of Ultra-Rapid Lispro Insulin with Control-IQ Technology in Adults, Adolescents, and Children with Type 1 DiabetesCarol J Levy, Ryan Bailey, Lori M Laffel, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
Diabetes Technology & Therapeutics|June 9, 2023
The Type 1 Diabetes and EXercise Initiative: Predicting Hypoglycemia Risk During Exercise for Participants with Type 1 Diabetes Using Repeated Measures Random ForestSimon Bergford, Michael C Riddell, Peter G Jacobs, et al.
The New England Journal of Medicine|September 7, 2022
Closed-Loop Therapy and Preservation of C-Peptide Secretion in Type 1 DiabetesCharlotte K Boughton, Janet M Allen, Julia Ware, et al.
Diabetes Technology & Therapeutics|September 29, 2022
A Multicenter Randomized Trial Evaluating the Insulin-Only Configuration of the Bionic Pancreas in Adults with Type 1 DiabetesDavida Kruger, Alex Kass, Jacqueline Lonier, et al.
Diabetes Care|June 26, 2024
Effect of 48 Months of Closed-Loop Insulin Delivery on Residual C-Peptide Secretion and Glycemic Control in Newly Diagnosed Youth With Type 1 Diabetes: A Randomized TrialJulia Ware, Charlotte K Boughton, Janet M Allen, et al.
Diabetologia|March 19, 2024
Associations between daily step count classifications and continuous glucose monitoring metrics in adults with type 1 diabetes: analysis of the Type 1 Diabetes Exercise Initiative (T1DEXI) cohortLauren V Turner, Martin Chase Marak, Robin L Gal, et al.
Journal of the Endocrine Society|September 1, 2020
Diabetes Telehealth Solutions: Improving Self-Management Through Remote Initiation of Continuous Glucose MonitoringRobin L Gal, Nathan J Cohen, Davida Kruger, et al.
Diabetes Technology & Therapeutics|June 28, 2022
WITHDRAWN: Positive Impact of the Bionic Pancreas on Diabetes Control in Youth 6-17 Years Old with Type 1 Diabetes: A Multicenter Randomized TrialLaurel H Messer, Bruce A Buckingham, Fran Cogen, et al.
Lancet (London, England)|January 17, 2021
A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trialRichard M Bergenstal, Revital Nimri, Roy W Beck, et al.
Diabetes Technology & Therapeutics|September 29, 2022
Positive Impact of the Bionic Pancreas on Diabetes Control in Youth 6-17 Years Old with Type 1 Diabetes: A Multicenter Randomized TrialLaurel H Messer, Bruce A Buckingham, Fran Cogen, et al.
Diabetes Technology & Therapeutics|May 2, 2024
Multicenter Evaluation of Ultra-Rapid Lispro Insulin with Control-IQ Technology in Adults, Adolescents, and Children with Type 1 DiabetesCarol J Levy, Ryan Bailey, Lori M Laffel, et al.
Pageof 10